292 related articles for article (PubMed ID: 9615271)
21. Genotype prevalence, viral load and outcome of hepatitis B virus precore mutant infection in stable patients and in patients after liver transplantation.
Ben-Ari Z; Ashur Y; Daudi N; Shmilovitz-Wiess H; Brown M; Sulkes J; Klein A; Mor E; Tur-Kaspa R; Shouval D
Clin Transplant; 2004 Aug; 18(4):415-22. PubMed ID: 15233819
[TBL] [Abstract][Full Text] [Related]
22. [Prevention and treatment of hepatitis B virus reinfection after liver transplantation].
Lu MQ; Cai CJ; Zhao H; Yang Y; Chen GH
Zhonghua Wai Ke Za Zhi; 2006 Jun; 44(11):742-4. PubMed ID: 16836920
[TBL] [Abstract][Full Text] [Related]
23. High viral load is associated with poor overall and recurrence-free survival of hepatitis B virus-related hepatocellular carcinoma after curative resection: a prospective cohort study.
Yang T; Lu JH; Zhai J; Lin C; Yang GS; Zhao RH; Shen F; Wu MC
Eur J Surg Oncol; 2012 Aug; 38(8):683-91. PubMed ID: 22621971
[TBL] [Abstract][Full Text] [Related]
24. Liver targeting of adenine arabinoside monophosphate (ara-AMP) by coupling to lactosaminated human serum albumin.
Fiume L; Busi C; Di Stefano G; Mattioli A; Torrani-Cerenzia M; Bonino F; Capra G; De Bernardi W; Ponzetto A; Lavezzo B
Ital J Gastroenterol; 1995 May; 27(4):189-92. PubMed ID: 8520036
[TBL] [Abstract][Full Text] [Related]
25. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
[TBL] [Abstract][Full Text] [Related]
26. Discontinuation of lamivudine treatment for hepatitis flare after kidney or heart transplantation in hepatitis B surface antigen-positive patients: A retrospective case series.
Huang YW; Liu CJ; Lai MY; Lee PH; Tsai MK; Wang SS; Lai MK; Kao JH
Clin Ther; 2006 Sep; 28(9):1327-34. PubMed ID: 17062306
[TBL] [Abstract][Full Text] [Related]
27. Living donor liver transplantation for hepatitis B associated liver diseases: a 10-year experience in a single center.
Ikegami T; Soejima Y; Ohta R; Taketomi A; Yoshizumi T; Harada N; Kayashima H; Maehara Y
Hepatogastroenterology; 2008; 55(85):1445-9. PubMed ID: 18795708
[TBL] [Abstract][Full Text] [Related]
28. Outcomes of hepatitis B virus recurrence after liver transplantation.
Han YS; Lee SK; Joh JW; Kim SJ; Kwon CH; Park JW; Kim DJ; Park JB
Transplant Proc; 2006 Sep; 38(7):2123-4. PubMed ID: 16980019
[TBL] [Abstract][Full Text] [Related]
29. Liver transplantation for viral hepatitis: the experience of the hepatobiliary center at Hospital Paul Brousse.
Samuel D; Feray C; Bismuth H
Clin Transpl; 1994; ():157-62. PubMed ID: 7547534
[TBL] [Abstract][Full Text] [Related]
30. Evolution of wild-type and precore mutant HBV infection after liver transplantation.
Torre F; Wong PY; Macartney M; Williams R; Naoumov NV
J Med Virol; 1999 Sep; 59(1):5-13. PubMed ID: 10440801
[TBL] [Abstract][Full Text] [Related]
31. [One year treatment with lamivudine in different hepatitis B virus related hepatic diseases].
Buti M; Cotrina M; Cruz de Castro E; Jardí R; Rodríguez F; Esteban R; Guardia J
Gastroenterol Hepatol; 1999 Mar; 22(3):117-21. PubMed ID: 10228320
[TBL] [Abstract][Full Text] [Related]
32. Change of hepatitis B virus DNA status in anti-HBc positive liver graft.
Kwon CH; Suh KS; Cho JY; Yi NJ; Jang JJ; Lee KU
Korean J Hepatol; 2006 Jun; 12(2):191-200. PubMed ID: 16804344
[TBL] [Abstract][Full Text] [Related]
33. Interferon vs. adenine arabinoside 5'-monophosphate in patients with anti-HBe-positive chronic hepatitis.
Buti M; Jardi R; Rodriguez-Frias F; Allende H; Cotrina M; Esteban R; Guardia J
J Med Virol; 1996 Aug; 49(4):325-8. PubMed ID: 8877766
[TBL] [Abstract][Full Text] [Related]
34. The incidence and clinical outcome of YMDD mutants in hepatitis B surface antigen-positive renal allograft recipients after prolonged lamivudine therapy.
Gwak GY; Huh W; Lee DH; Choi MS; Lee JH; Koh KC; Kim SJ; Joh JW; Oh HY
Transplant Proc; 2007 Dec; 39(10):3121-6. PubMed ID: 18089336
[TBL] [Abstract][Full Text] [Related]
35. Residual hepatitis B virus particles in liver transplant recipients receiving lamivudine: PCR quantitation of HBV DNA and ELISA of preS1 antigen.
Petit MA; Buffello-Le Guillou D; Roche B; Dussaix E; Duclos-Vallée JC; Féray C; Samuel D
J Med Virol; 2001 Nov; 65(3):493-504. PubMed ID: 11596084
[TBL] [Abstract][Full Text] [Related]
36. Outcome of lamivudine resistant hepatitis B virus mutant post-liver transplantation on lamivudine monoprophylaxis.
Chan HL; Chui AK; Lau WY; Chan FK; Hui AY; Rao AR; Wong J; Lai EC; Sung JJ
Clin Transplant; 2004 Jun; 18(3):295-300. PubMed ID: 15142051
[TBL] [Abstract][Full Text] [Related]
37. Prolonged survival in fibrosing cholestatic hepatitis with long-term ganciclovir therapy.
Jamal H; Regenstein F; Farr G; Perrillo RP
Am J Gastroenterol; 1996 May; 91(5):1027-30. PubMed ID: 8633545
[TBL] [Abstract][Full Text] [Related]
38. [Recurrence of virus B hepatitis after liver transplantation].
Gugenheim J; Crafa F; Fabiani P; Militerno G; Goubaux B; Saint-Paul MC; Ouzan D; Mouiel J
Gastroenterol Clin Biol; 1992; 16(5):430-3. PubMed ID: 1326456
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of adenine arabinoside 5'-monophosphate in kidney transplant recipients with chronic active hepatitis B.
Pol S; Saltiel C; Legendre C; Carnot F; Driss F; Berthelot P; Bréchot C; Ruet C; Kreis H
Nephrol Dial Transplant; 1994; 9(7):820-3. PubMed ID: 7526277
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of woodchuck hepatitis virus replication by adenine arabinoside monophosphate coupled to lactosaminated poly-L-lysine and administered by intramuscular route.
Fiume L; Di Stefano G; Busi C; Mattioli A; Rapicetta M; Giuseppetti R; Ciccaglione AR; Argentini C
Hepatology; 1995 Oct; 22(4 Pt 1):1072-7. PubMed ID: 7557853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
